BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Elekta's Versa HD System Now Features Automated Breath Hold Gating for Improved Breast and Lung Radiotherapy


8/22/2013 9:18:33 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CRAWLEY, England, Aug. 21, 2013 /PRNewswire/ -- Users of Elekta's groundbreaking linear accelerator, Versa HD, can now bring target immobilization to new levels through automated gating with Active Breathing Coordinator. For anatomies affected by respiratory motion, such as lung, liver and breast, Active Breathing Coordinator provides non-invasive, internal immobilization of the target, triggering radiation delivery when anatomy is immobilized.

Automated gating with Active Breathing Coordinator recently received CE marking from the European Union and 510(k) clearance from the U.S. Food and Drug Administration (FDA), and in combination with Elekta's Response gating interface, provides additional benefits to both the Versa HD clinically-tailored solutions for treating breast and lung cancers.

Active Breathing Coordinator helps patients pause their breathing at a precisely indicated tidal volume a deep-inspiration breath-hold which increases the distance between the tumor and critical structures, resulting in the ability to reduce doses to the critical structures.

By consistently immobilizing the target in an identifiable, repeatable and stationary position, clinicians are better able to reduce tumor margins and implement dose escalation and hypofractionation strategies, such as Stereotactic Body Radiation Therapy (SBRT). Automated beam delivery increases clinical confidence and efficiency, in addition to reducing treatment times over manual techniques.

"We use Active Breathing Coordinator for lung and liver cancer treatments, and in combination with High Dose Rate mode that is now available with Versa HD, we are able to deliver breath-hold gated SBRT treatments with IGRT in a standard treatment time slot of 15 minutes," says Prof. Frank Lohr, Vice Chairman, University Medical Centre Mannheim.

Versa HD is a sophisticated radiation treatment delivery system designed to enhance the management of cancer care and treat a broad spectrum of tumors throughout the body. The market's most advanced linear accelerator, Versa HD is a single system capable of delivering conventional therapies for indications commonly seen in the clinic, while also permitting treatment of complex cancers that require exceptional targeting accuracy.

Versa HD and Active Breathing Coordinator with automated gating are not available for sale in all markets.

For further information, please contact:
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, email: johan.andersson@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

SOURCE Elekta



Help employers find you! Check out all the jobs and post your resume.



Elekta
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES